$200.00 USD
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Advanced Nanoformulations: Theranostic Nanosystems, Volume Three examines the applications of nanotherapeutic systems and nanodiagnostics in relation to polymeric nanosystems. In the last decade, numerous biopolymers have been utilized to prepare polymeric nanosystems for therapeutic applications. These biopolymers include polylactic acid, polylactide-co-glycolide, polycaprolactone, acrylic polymers, cellulose and cellulose derivatives, alginates, chitosan, gellan gum, gelatin, albumin, chontroitin sulfate, hyaluronic acid, guar gum, gum Arabic, gum tragacanth, xanthan gum, and starches. Besides these biopolymers, grafted polymers are also being used as advanced polymeric materials to prepare many theranostic nanocarriers and nanoformulations. This book explores the array of polymeric nanosystems to understand therapeutic potentials.

It will be useful to pharmaceutical scientists, including industrial pharmacists and analytical scientists, health care professionals, and regulatory scientists actively involved in the pharmaceutical product and process development of tailor-made polysaccharides in drug delivery applications.

  • Contains in-depth discussions of the advanced formulations using nanosystems including high-quality graphics, flowcharts, and graphs for enhanced understanding
  • Reviews the literature on advanced formulations while also suggesting new avenues
  • Includes contributions in all areas of advanced formulations, providing a thorough and interdisciplinary work

1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. xxi 7. Preface - p. xxix 8. Chapter 1. Advanced nanoformulations for theranostics: current status and challenges - p. 1 9. Chapter 2. Chitosan-based nanosuspensions for ocular diagnosis and therapy - p. 21 10. Chapter 3. Nanoemulsions in theranostics - p. 51 11. Chapter 4. Self-nanoemulsifying systems for drug delivery therapeutics - p. 81 12. Chapter 5. Polymeric micelles for therapeutics and diagnosis - p. 97 13. Chapter 6. Dendrimers for theranostic applications - p. 159 14. Chapter 7. Nanogels as theranostic platforms: drug delivery, targeting, and imaging - p. 181 15. Chapter 8. Nanocrystals as a versatile platform for theranostic applications - p. 209 16. Chapter 9. Niosome as a promising vesicular tool for therapy and diagnosis - p. 241 17. Chapter 10. Cubosomes for enhanced drug delivery and targeting therapeutics - p. 263 18. Chapter 11. Aquasomes: a novel nanocarrier system for drug delivery - p. 289 19. Chapter 12. Nanostructured lipid carriers: a novel platform for therapeutics - p. 311 20. Chapter 13. Self-assembled protein-drug nanoparticles for enhanced drug delivery and targeting cancer therapeutics - p. 341 21. Chapter 14. Stimuli-responsive nanosystems as smart nanotheranostics - p. 363 22. Chapter 15. Nanoconjugates and nanoconjugate formulations for improving drug delivery and therapeutic efficacy - p. 397 23. Chapter 16. Nanophytomedicines: a novel approach for improving therapeutics via delivery of herbal medicine - p. 431 24. Chapter 17. Multifunctional nanocomposites for theranostics - p. 467 25. Chapter 18. Nanofibers for diagnosis, drug delivery, and therapy - p. 503 26. Chapter 19. Nanovectors for theranostic applications - p. 519 27. Chapter 20. Nanoprobes for advanced nanotheranostic applications - p. 557 28. Chapter 21. Nanorobots for improved theranostic applications - p. 587 29. Chapter 22. Nanoghosts for therapeutic applications - p. 613 30. Chapter 23. Biomimetic nanosystems in theranostics - p. 645 31. Chapter 24. Nanoformulations for cardiovascular therapy - p. 669 32. Chapter 25. Advanced nanoformulations for neurological therapeutics - p. 685 33. Chapter 26. Advanced nanoformulations for targeting, imaging, and therapy - p. 719 34. Chapter 27. Cell-penetrating peptide(s): Design, synthesis, and site-specific nanotheranostic applications in cancer therapy - p. 745 35. Chapter 28. Development of nanographene oxide/2-hydroxyethyl methacrylate/gelatin/alginate and nanotitanium dioxide/2-hydroxyethyl methacrylate/gelatin/alginate polymeric systems for biomedical applications - p. 771 36. Index - p. 811

Descripcion
Descripción

Advanced Nanoformulations: Theranostic Nanosystems, Volume Three examines the applications of nanotherapeutic systems and nanodiagnostics in relation to polymeric nanosystems. In the last decade, numerous biopolymers have been utilized to prepare polymeric nanosystems for therapeutic applications. These biopolymers include polylactic acid, polylactide-co-glycolide, polycaprolactone, acrylic polymers, cellulose and cellulose derivatives, alginates, chitosan, gellan gum, gelatin, albumin, chontroitin sulfate, hyaluronic acid, guar gum, gum Arabic, gum tragacanth, xanthan gum, and starches. Besides these biopolymers, grafted polymers are also being used as advanced polymeric materials to prepare many theranostic nanocarriers and nanoformulations. This book explores the array of polymeric nanosystems to understand therapeutic potentials.

It will be useful to pharmaceutical scientists, including industrial pharmacists and analytical scientists, health care professionals, and regulatory scientists actively involved in the pharmaceutical product and process development of tailor-made polysaccharides in drug delivery applications.

  • Contains in-depth discussions of the advanced formulations using nanosystems including high-quality graphics, flowcharts, and graphs for enhanced understanding
  • Reviews the literature on advanced formulations while also suggesting new avenues
  • Includes contributions in all areas of advanced formulations, providing a thorough and interdisciplinary work

1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. xxi 7. Preface - p. xxix 8. Chapter 1. Advanced nanoformulations for theranostics: current status and challenges - p. 1 9. Chapter 2. Chitosan-based nanosuspensions for ocular diagnosis and therapy - p. 21 10. Chapter 3. Nanoemulsions in theranostics - p. 51 11. Chapter 4. Self-nanoemulsifying systems for drug delivery therapeutics - p. 81 12. Chapter 5. Polymeric micelles for therapeutics and diagnosis - p. 97 13. Chapter 6. Dendrimers for theranostic applications - p. 159 14. Chapter 7. Nanogels as theranostic platforms: drug delivery, targeting, and imaging - p. 181 15. Chapter 8. Nanocrystals as a versatile platform for theranostic applications - p. 209 16. Chapter 9. Niosome as a promising vesicular tool for therapy and diagnosis - p. 241 17. Chapter 10. Cubosomes for enhanced drug delivery and targeting therapeutics - p. 263 18. Chapter 11. Aquasomes: a novel nanocarrier system for drug delivery - p. 289 19. Chapter 12. Nanostructured lipid carriers: a novel platform for therapeutics - p. 311 20. Chapter 13. Self-assembled protein-drug nanoparticles for enhanced drug delivery and targeting cancer therapeutics - p. 341 21. Chapter 14. Stimuli-responsive nanosystems as smart nanotheranostics - p. 363 22. Chapter 15. Nanoconjugates and nanoconjugate formulations for improving drug delivery and therapeutic efficacy - p. 397 23. Chapter 16. Nanophytomedicines: a novel approach for improving therapeutics via delivery of herbal medicine - p. 431 24. Chapter 17. Multifunctional nanocomposites for theranostics - p. 467 25. Chapter 18. Nanofibers for diagnosis, drug delivery, and therapy - p. 503 26. Chapter 19. Nanovectors for theranostic applications - p. 519 27. Chapter 20. Nanoprobes for advanced nanotheranostic applications - p. 557 28. Chapter 21. Nanorobots for improved theranostic applications - p. 587 29. Chapter 22. Nanoghosts for therapeutic applications - p. 613 30. Chapter 23. Biomimetic nanosystems in theranostics - p. 645 31. Chapter 24. Nanoformulations for cardiovascular therapy - p. 669 32. Chapter 25. Advanced nanoformulations for neurological therapeutics - p. 685 33. Chapter 26. Advanced nanoformulations for targeting, imaging, and therapy - p. 719 34. Chapter 27. Cell-penetrating peptide(s): Design, synthesis, and site-specific nanotheranostic applications in cancer therapy - p. 745 35. Chapter 28. Development of nanographene oxide/2-hydroxyethyl methacrylate/gelatin/alginate and nanotitanium dioxide/2-hydroxyethyl methacrylate/gelatin/alginate polymeric systems for biomedical applications - p. 771 36. Index - p. 811

Indice
Autores
Muestra
Ficha Técnica